GWC Technologies

The "carbon-on-metal" technology would address limitations to gold as a material for protein array development, making such arrays less susceptible to non-specific binding, less prone to denaturing proteins, and more reusable.

CEO Tim Burland said the company hopes to be able to make its carbon-coated-on-gold surfaces available by the end of the year, and to expand its business into applied markets, such as bioengineering and environmental and agricultural testing.

The Madison, Wis.-based company’s imaging systems analyze protein arrays made on gold biochips, which enables label-free analysis that may “accurately reflect how proteins function in real life,” the company said.

Funding Update

Premium

NSF Microarray Grants Awarded April 8 — June 23, 2008

New Products

Premium

Agilent, GWC Technologies, Pall Life Sciences, AnaSpec

New Product Watch

Premium

GWC Technologies, BioTrove, Stone Bond Technologies

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.